This post appeared yesterday on RealMoney. Click here for a free trial, and enjoy incisive commentary all day, every day.

There was almost nothing good that happened today. I say almost, because we saw something amazing happen. WellPoint ( WLP) reported a monster quarter. Just monster. I know away from this article, there is controversy brewing -- homegrown! -- about what might be going on in the Senate and Wellpoint.

All I can tell you is that this company made so much money, it couldn't even hide it. I used to own the stock for Action Alerts PLUS, but sold it believing that it would be bruised if not broken by the healthcare reform plans of President Obama.

Instead, we have something pretty exciting brewing here. The stock, despite the hideous day, outperformed the stock market, EVEN THOUGH TOMORROW WILL BE NANCY PELOSI'S DAY to take apart the HMO industry. Everyone knew it, but the stock barely got hit. Why? Because Pelosi's not the driver here. The Senate is. Although Chuck Schumer says he has 60 votes for reform, I believe the reform that passes will not be a reform that does anything more than nick WellPoint.

As of today, Wellpoint is a double-digit grower that sells at 8 times earnings. I don't care if health care reform clips the thing for 25 cents a share -- and I doubt it will even be a dime -- this stock is too cheap. I know the chart is bad. I know the optics are bad.
Meet Cramer and Get Your Signed Copy of New York Times Best Seller Getting Back to Even

Tuesday , Nov. 17, 7 p.m. Barnes & Noble, Manhattan(33 E. 17th St.)

But the earnings are good and going to stay good.

This is pretty much the end of the line for health care reform. I am betting that WLP will get a multiple of at least 10 times when the health care debate is over. Let's cut 25 cents off the earnings. You still get to $53 a share.

That's my new WLP target in 72 hours when I think, at last, the worst of the headline noise will be over.

At the time of publication, Cramer held no positions in the stocks mentioned.

Special note from Jim: You can learn my time-tested ways to trade smart, even in this market. All my latest thinking is in my brand new book, Getting Back to Even, which I'll send to you as part of a special promotion when you sign up for my service for a limited time. So if you sign up now, you'll get to see how I'm playing these stocks in my portfolio today, plus, I'll teach you how you can play these stocks to help your portfolio get back to even.

Thanks to all of you who helped my book become number one on the New York Times bestseller list of How-to and Advice Books.

Cramer's Upcoming Book Signings

Tuesday , Nov. 17, 7 p.m. Barnes & Noble, Manhattan(33 East 17th St.)

Jim Cramer is co-founder and chairman of He contributes daily market commentary for's sites and serves as an adviser to the company's CEO. Outside contributing columnists for and, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. To order Cramer's newest book -- "Jim Cramer's Stay Mad for Life: Get Rich, Stay Rich (Make Your Kids Even Richer)," click here. Click here to order "Mad Money: Watch TV, Get Rich," click here to order "Real Money: Sane Investing in an Insane World," click here to get "You Got Screwed!" and click here for Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he appreciates your feedback and invites you to send comments by clicking here. has a revenue-sharing relationship with under which it receives a portion of the revenue from purchases by customers directed there from